RE:volumeI think there is interest in this stock but for most it is a wait and see situation. I think you will see some large volume if we hear that Shiseido is going to settle outside of arbitration or the Dermaprecise has finished testing at the Monasterium Lab (mid February) with good results.
The problem with a penny stock like this is there can be radical swings up and down as we have seen lately. Each day there are people fishing for cheap shares and very few sellers willing to sell at these low prices. The other problem is there is a large range of average cost of shares. From as little as $.135 to over $1.00 which comes with the same range of selling thresholds.